Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Instituto Nacional de Cancerologia de Mexico
ClinicalTrials.gov Identifier:
NCT00437853
First received: February 20, 2007
Last updated: NA
Last verified: February 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: February 2007
  Estimated Primary Completion Date: No date given